Cargando…
Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors
Isocoumarins, isomeric to comarins which act as effective carbonic anhydrase (CA, EC 4.2.1.1) inhibitors, were investigated for the first time as inhibitors of this enzyme. A series of 3-substituted and 3,4-disubstituted isocoumarins incorporating phenylhydrazone, 1-phenyl-pyrazole and pyrazolo-subs...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865125/ https://www.ncbi.nlm.nih.gov/pubmed/35188025 http://dx.doi.org/10.1080/14756366.2022.2041630 |
_version_ | 1784655588104339456 |
---|---|
author | Onyılmaz, Mehmet Koca, Murat Bonardi, Alessandro Degirmenci, Mustafa Supuran, Claudiu T. |
author_facet | Onyılmaz, Mehmet Koca, Murat Bonardi, Alessandro Degirmenci, Mustafa Supuran, Claudiu T. |
author_sort | Onyılmaz, Mehmet |
collection | PubMed |
description | Isocoumarins, isomeric to comarins which act as effective carbonic anhydrase (CA, EC 4.2.1.1) inhibitors, were investigated for the first time as inhibitors of this enzyme. A series of 3-substituted and 3,4-disubstituted isocoumarins incorporating phenylhydrazone, 1-phenyl-pyrazole and pyrazolo-substituted pyrimidine trione/thioxo-pyrimidine dione moieties were investigated for their interaction with four human (h) CA isoforms, hCA I, II, IX and XII, known to be important drug targets. hCA I and II were not inhibited by these compounds, whereas hCA IX and XII were inhibited in the low micromolar range by the less bulky derivatives. The inhibition constants ranged between 2.7–78.9 µM against hCA IX and of 1.2–66.5 µM against hCA XII. As for the coumarins, we hypothesise that the isocoumarins are hydrolysed by the esterase activity of the enzyme with formation of 2-carboxy-phenylacetic aldehydes which act as CA inhibitors. Isocoumarins represent a new class of CA inhibitors. |
format | Online Article Text |
id | pubmed-8865125 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-88651252022-02-24 Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors Onyılmaz, Mehmet Koca, Murat Bonardi, Alessandro Degirmenci, Mustafa Supuran, Claudiu T. J Enzyme Inhib Med Chem Brief Report Isocoumarins, isomeric to comarins which act as effective carbonic anhydrase (CA, EC 4.2.1.1) inhibitors, were investigated for the first time as inhibitors of this enzyme. A series of 3-substituted and 3,4-disubstituted isocoumarins incorporating phenylhydrazone, 1-phenyl-pyrazole and pyrazolo-substituted pyrimidine trione/thioxo-pyrimidine dione moieties were investigated for their interaction with four human (h) CA isoforms, hCA I, II, IX and XII, known to be important drug targets. hCA I and II were not inhibited by these compounds, whereas hCA IX and XII were inhibited in the low micromolar range by the less bulky derivatives. The inhibition constants ranged between 2.7–78.9 µM against hCA IX and of 1.2–66.5 µM against hCA XII. As for the coumarins, we hypothesise that the isocoumarins are hydrolysed by the esterase activity of the enzyme with formation of 2-carboxy-phenylacetic aldehydes which act as CA inhibitors. Isocoumarins represent a new class of CA inhibitors. Taylor & Francis 2022-02-21 /pmc/articles/PMC8865125/ /pubmed/35188025 http://dx.doi.org/10.1080/14756366.2022.2041630 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Report Onyılmaz, Mehmet Koca, Murat Bonardi, Alessandro Degirmenci, Mustafa Supuran, Claudiu T. Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors |
title | Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors |
title_full | Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors |
title_fullStr | Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors |
title_full_unstemmed | Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors |
title_short | Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors |
title_sort | isocoumarins: a new class of selective carbonic anhydrase ix and xii inhibitors |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865125/ https://www.ncbi.nlm.nih.gov/pubmed/35188025 http://dx.doi.org/10.1080/14756366.2022.2041630 |
work_keys_str_mv | AT onyılmazmehmet isocoumarinsanewclassofselectivecarbonicanhydraseixandxiiinhibitors AT kocamurat isocoumarinsanewclassofselectivecarbonicanhydraseixandxiiinhibitors AT bonardialessandro isocoumarinsanewclassofselectivecarbonicanhydraseixandxiiinhibitors AT degirmencimustafa isocoumarinsanewclassofselectivecarbonicanhydraseixandxiiinhibitors AT supuranclaudiut isocoumarinsanewclassofselectivecarbonicanhydraseixandxiiinhibitors |